169 related articles for article (PubMed ID: 7301610)
1. Carcinoembryonic antigen estimation in cerebrospinal fluid in patients with metastatic breast cancer.
Dearnaley DP; Patel S; Powles TJ; Coombes RC
Oncodev Biol Med; 1981; 2(4):305-11. PubMed ID: 7301610
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid biochemical markers of central nervous system metastases.
Schold SC; Wasserstrom WR; Fleisher M; Schwartz MK; Posner JB
Ann Neurol; 1980 Dec; 8(6):597-604. PubMed ID: 7212647
[TBL] [Abstract][Full Text] [Related]
3. [A correlative study of cytology and carcinoembryonic antigen determination in cerebrospinal fluid in the diagnosis of breast cancer cerebro-meningeal metastases (author's transl)].
Fontaniere B; Ardiet C; Clavel M; Lahneche B; Clavel E; Faucon M
Arch Anat Cytol Pathol; 1981; 29(5):287-90. PubMed ID: 7305463
[No Abstract] [Full Text] [Related]
4. Immunocytochemical demonstration of carcinoembryonic antigen in cerebrospinal fluid with carcinomatous meningitis from rectal cancer.
Kobayashi TK; Yamaki T; Yoshino E; Higuchi T; Kamachi M
Acta Cytol; 1984; 28(4):430-4. PubMed ID: 6380184
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid and serum carcinoembryonic antigen in brain tumors.
Batabyal SK; Ghosh B; Sengupta S; Ghosh SN; Chatterjee R
Neoplasma; 2003; 50(5):377-9. PubMed ID: 14628092
[TBL] [Abstract][Full Text] [Related]
6. The cytopathology of cerebrospinal fluid. II. Metastatic cancer, meningeal carcinomatosis and primary central nervous system neoplasms.
Bigner SH; Johnston WW
Acta Cytol; 1981; 25(5):461-79. PubMed ID: 7025541
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple Discharge.
Mori T; Inaji H; Higashiyama M; Yayoi E; Izuo M; Ueno E; Enomoto K; Kasumi F; Sakamoto G; Tominaga T
Jpn J Clin Oncol; 1989 Dec; 19(4):373-9. PubMed ID: 2691732
[TBL] [Abstract][Full Text] [Related]
8. CSF carcinoembryonic antigen in meningeal carcinomatosis from breast cancer.
Yap BS; Yap HY; Fritsche HA; Blumenschein G; Bodey GP
JAMA; 1980 Oct; 244(14):1601-3. PubMed ID: 7420663
[TBL] [Abstract][Full Text] [Related]
9. [Brain metastasis and the carcinoembryonic antigen].
Noris-García E; Escobar-Pérez X
Rev Neurol; 2004 Feb 1-15; 38(3):267-70. PubMed ID: 14963857
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of beta 2-microglobulin and carcinoembryonic antigen in intracranial tumors].
Suzuki Y; Ishii R; Otsuka R; Ogawa Y; Kikuoka M; Hirano K; Tanaka R
No To Shinkei; 1987 Oct; 39(10):965-70. PubMed ID: 3325088
[TBL] [Abstract][Full Text] [Related]
11. The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid.
Jacobi C; Reiber H; Felgenhauer K
J Neurol; 1986 Nov; 233(6):358-61. PubMed ID: 3806144
[TBL] [Abstract][Full Text] [Related]
12. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen in patients with untreated central nervous system tumors.
Kido DK; Dyce BJ; Haverback BJ; Rumbaugh CL
Bull Los Angeles Neurol Soc; 1976 Apr; 41(2):47-54. PubMed ID: 1030651
[TBL] [Abstract][Full Text] [Related]
14. [Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis].
Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
No Shinkei Geka; 1991 Dec; 19(12):1135-41. PubMed ID: 1766538
[TBL] [Abstract][Full Text] [Related]
15. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
[TBL] [Abstract][Full Text] [Related]
16. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study.
Guadagni F; Ferroni P; Carlini S; Mariotti S; Spila A; Aloe S; D'Alessandro R; Carone MD; Cicchetti A; Ricciotti A; Venturo I; Perri P; Di Filippo F; Cognetti F; Botti C; Roselli M
Clin Cancer Res; 2001 Aug; 7(8):2357-62. PubMed ID: 11489813
[TBL] [Abstract][Full Text] [Related]
17. Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer.
Fleisher M; Wasserstrom WR; Schold SC; Schwartz MK; Posner JB
Cancer; 1981 Jun; 47(11):2654-9. PubMed ID: 7260857
[TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen in cerebrospinal fluid of adult brain-tumor patients.
Hill S; Martin E; Ellison EC; Hunt WE
J Neurosurg; 1980 Nov; 53(5):627-32. PubMed ID: 7431072
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid carcinoembryonic antigen in patients with metastatic and nonmetastatic neurological diseases.
Twijnstra A; Nooyen WJ; van Zanten AP; Hart AA; Ongerboer de Visser BW
Arch Neurol; 1986 Mar; 43(3):269-72. PubMed ID: 3947276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]